PAR PHARM INC FDA Approval ANDA 206113

ANDA 206113

PAR PHARM INC

FDA Drug Application

Application #206113

Application Sponsors

ANDA 206113PAR PHARM INC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORALEQ 0.5MG BASE0ALOSETRON HYDROCHLORIDEALOSETRON HYDROCHLORIDE
002TABLET;ORALEQ 1MG BASE0ALOSETRON HYDROCHLORIDEALOSETRON HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2018-02-23STANDARD
LABELING; LabelingSUPPL2AP2019-12-06STANDARD
REMS; REMSSUPPL4AP2021-10-18
REMS; REMSSUPPL5AP2022-05-05

Submissions Property Types

ORIG1Null15
SUPPL2Null15
SUPPL4Null15
SUPPL5Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

PAR PHARM INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206113
            [companyName] => PAR PHARM INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ALOSETRON HYDROCHLORIDE","activeIngredients":"ALOSETRON HYDROCHLORIDE","strength":"EQ 0.5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ALOSETRON HYDROCHLORIDE","activeIngredients":"ALOSETRON HYDROCHLORIDE","strength":"EQ 1MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/23\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"12\/06\/2019","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-12-06
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.